gene 1,031 words KG: ARID2 2026-03-22
kind:genesection:genesstate:published
Contents

ARID2 (AT-Rich Interaction Domain 2)

🧬 Gene Info
Gene SymbolARID2
Full NameAT-Rich Interaction Domain 2
Chromosome12q12
Functionis a defining subunit that distinguishes PBAF from canonical BAF (cBAF) and non-canonical BAF (ncBAF) complexes.
UniProt ID[Q68CP9](https://www.uniprot.org/uniprot/Q68CP9)
Ensembl IDENSG00000189079
GeneCardsARID2
Human Protein AtlasARID2
Chromatin targetingThe ARID domain of ARID2 recognizes AT-rich DNA sequences prevalent in gene regulatory regions, directing PBAF to specific genomic loci including neural gene enhancers and promoters
Complex assemblyARID2 serves as a scaffolding subunit that stabilizes PBAF-specific components including PBRM1 (polybromo-1/BAF180), BRD7, and PHF10/BAF45a
Enhancer regulationPBAF is preferentially recruited to super-enhancers and poised enhancers marked by H3K4me1, where it facilitates enhancer activation during neural differentiation
Interferon signalingARID2 is required for interferon-stimulated gene (ISG) expression, linking chromatin remodeling to innate immune responses in microglia and astrocytes
DNA damage responsePBAF is rapidly recruited to DNA double-strand breaks, where it promotes non-homologous end joining (NHEJ) repair by facilitating access of repair machinery to damaged chromatin
CerebellumPurkinje cells show robust ARID2 expression, reflecting requirements for cerebellar chromatin regulation
Developing brainPeak expression during embryonic neurogenesis (E12-E18 in mouse), with maintained but reduced adult levels
Associated Diseasesneurodegeneration
DatabasesGeneCardsNCBI GeneHPASTRING

Knowledge Graph

Related Hypotheses (8)

Chromatin Accessibility Restoration via BRD4 Modulation
Score: 0.56
Dual-Domain Antibodies with Engineered Fc-FcRn Affinity Modu
Score: 0.57
Competitive APOE4 Domain Stabilization Peptides
Score: 0.56
Astrocyte-Mediated Neuronal Epigenetic Rescue
Score: 0.48
Interfacial Lipid Mimetics to Disrupt Domain Interaction
Score: 0.46

Related Analyses (6)

TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived
Epigenetic reprogramming in aging neurons
neurodegeneration · archived
Circuit-level neural dynamics in neurodegeneration
neuroscience · archived

Related Experiments (15)

Animal Model Comparison for Neurodegenerative Disease Therap
clinical · proposed · Score: 0.40
Endocannabinoid System Dysfunction Validation in Parkinson's
clinical · proposed · Score: 0.40
ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40
Glymphatic-Circadian Axis Enhancement Therapy for Parkinson'
clinical · proposed · Score: 0.40
Cytochrome Therapeutics
clinical · proposed · Score: 0.40

See Also (1)

Neurodegeneration
disease · KG edge: implicated_in

Knowledge Graph (2 edges)

ARID2 data_in benchmark_ot_ad_answer_key:ARID2
benchmark_ot_ad_answer_key:ARID2 data_in ARID2